Gilead Sciences Inc (GILD)

Fixed asset turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue (ttm)	US$ in thousands	28,749,000	28,295,000	27,800,000	27,450,000	27,116,000	27,390,000	27,382,000	27,043,000	27,281,000	27,136,000	27,515,000	27,472,000	27,305,000	27,482,000	26,638,000	25,564,000	24,689,000	23,147,000	22,174,000	22,716,000
Property, plant and equipment	US$ in thousands	—	—	—	—	—	—	5,540,000	5,479,000	5,475,000	5,349,000	5,299,000	5,253,000	5,121,000	5,037,000	4,996,000	4,990,000	4,967,000	4,810,000	4,653,000	4,564,000
Fixed asset turnover		—	—	—	—	—	—	4.94	4.94	4.98	5.07	5.19	5.23	5.33	5.46	5.33	5.12	4.97	4.81	4.77	4.98

December 31, 2024 calculation

Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $28,749,000K ÷ $—K
= —

Gilead Sciences Inc's fixed asset turnover has shown a steady increase from 4.98 in March 2020 to 5.07 in September 2022, indicating that the company is generating more sales revenue relative to its investment in fixed assets. This improvement suggests that Gilead is efficiently utilizing its fixed assets to generate revenue.

However, there was a slight decline in fixed asset turnover to 4.98 by December 2024, which may indicate a decrease in sales relative to fixed assets invested or an increase in the value of fixed assets. It is important for the company to monitor this ratio to ensure the efficient utilization of its fixed assets.

The absence of data for the periods beyond September 2023 makes it challenging to assess the current trend in fixed asset turnover. Gilead should continue to monitor and optimize its fixed asset turnover to maximize operational efficiency and profitability.